CMMB

CHEMOMAB THERAPEUTICS LTD

CMMB·16385C203·US·ADR·Healthcare - Biotechnology-Activist

CMMB (CHEMOMAB THERAPEUTICS LTD) is held by 6 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($154,404), RHUMBLINE ADVISERS ($49,457), XTX Topco Ltd ($25,899). Net institutional sentiment: Mixed.

6
Holders
$269,808
Total Value
38% (8)
Consensus
3 buying - 5 selling
13F: Insider & Congress: Updated regularly
CMMB

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jun 1, 2026 · Activists Aug 13, 2026 · Congress none

ActivistTGTouchstone Global Investments Pty Ltd5.2%Aug 13, 2026
ActivistHHHBM Healthcare Investments (Cayman) Ltd.12.5%Jul 16, 2026
InsiderMAMor George AdiBuy $10KMay 29, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
95,311(+48.5%)$154,4040.0%+58.56%
21
Increased
30,529(+66.2%)$49,4570.0%+9.19%
20
Decreased
15,987(-14.2%)$25,8990.0%+57.93%
0
New
14,341$23,2320.0%+59.88%
26
Decreased
6,805(-19.2%)$11,0240.0%-45.75%
0
Decreased
3,575(-21.9%)$5,7920.0%-39.06%
0
Exited
0(-100.0%)$21,1810.0%-9.50%
0
Exited
0(-100.0%)$130.0%-10.31%
0
CMMBCMMBCHEMOMAB THERAPEUTICS LTD

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used